1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing applications in molecular diagnostics
5.1.1.2. Increasing prevalence of chronic medical and genetic disorders, such as cancer and cardiovascular diseases (CVDs) globally
5.1.1.3. Improving synthetic delivery carriers and chemical modifications to RNA
5.1.2. Restraints
5.1.2.1. Stringent FDA regulations
5.1.2.2. Changing reimbursement environment
5.1.3. Opportunities
5.1.3.1. Improving synthetic delivery carriers and chemical modifications to RNA
5.1.3.2. Extensive research and development (R&D) activities in the fields of nanotechnology and molecular diagnostics
5.1.3.3. Along with overall improvements in the healthcare infrastructure
5.1.4. Challenges
5.1.4.1. Unstable potentially immunogenic nature of RNA
5.2. Cumulative Impact of COVID-19

6. RNA Interference Technology Market, by Type
6.1. Introduction
6.2. dsRNA
6.3. miRNA
6.4. siRNA

7. RNA Interference Technology Market, by Therapeutics
7.1. Introduction
7.2. Autoimmune Hepatitis
7.3. Hepatitis B and C
7.4. Neurological Disorders
7.5. Oncology

8. RNA Interference Technology Market, by Application
8.1. Introduction
8.2. Drug Discovery and Development
8.3. Therapeutics
8.3.1. Autoimmune Hepatitis
8.3.2. Hepatitis B and C
8.3.3. Neurological Disorders
8.3.4. Oncology
8.3.5. Respiratory Disorders

9. Americas RNA Interference Technology Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific RNA Interference Technology Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa RNA Interference Technology Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Alnylam Pharmaceuticals Inc.
13.2. Ambion, Inc
13.3. Arcturus Therapeutics
13.4. Arrowhead Pharmaceuticals, Inc.
13.5. AstraZeneca plc
13.6. Atalanta Therapeutics
13.7. Bioneer Corporation
13.8. CureVac AG
13.9. Dicerna Pharmaceuticals
13.10. Gotham Therapeutics Corp.
13.11. Gradalis, Inc.
13.12. Invitrogen
13.13. Ionis Pharmaceuticals
13.14. Ionis Pharmaceuticals, Inc.
13.15. Merck KGaA
13.16. Phio Pharmaceuticals Inc.
13.17. Qiagen NV
13.18. Quark Pharmaceuticals, Inc.
13.19. Sanofi S.A.
13.20. Silence Therapeutics
13.21. Sirnaomics, Inc.
13.22. Thermo Fisher Scientific Inc.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2020 VS 2027 (%)
FIGURE 4. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2020 VS 2027 (USD BILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2027
FIGURE 6. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DSRNA, 2018-2027 (USD BILLION)
FIGURE 7. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DSRNA, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 8. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MIRNA, 2018-2027 (USD BILLION)
FIGURE 9. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MIRNA, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 10. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SIRNA, 2018-2027 (USD BILLION)
FIGURE 11. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SIRNA, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 12. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2020 VS 2027 (%)
FIGURE 13. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2020 VS 2027 (USD BILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2027
FIGURE 15. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY AUTOIMMUNE HEPATITIS, 2018-2027 (USD BILLION)
FIGURE 16. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY AUTOIMMUNE HEPATITIS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 17. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY HEPATITIS B AND C, 2018-2027 (USD BILLION)
FIGURE 18. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY HEPATITIS B AND C, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2027 (USD BILLION)
FIGURE 20. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 21. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2027 (USD BILLION)
FIGURE 22. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 23. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2020 VS 2027 (%)
FIGURE 24. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2020 VS 2027 (USD BILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2027
FIGURE 26. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2027 (USD BILLION)
FIGURE 27. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 28. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2027 (USD BILLION)
FIGURE 29. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 30. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY AUTOIMMUNE HEPATITIS, 2018-2027 (USD BILLION)
FIGURE 31. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY AUTOIMMUNE HEPATITIS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 32. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY HEPATITIS B AND C, 2018-2027 (USD BILLION)
FIGURE 33. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY HEPATITIS B AND C, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 34. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2027 (USD BILLION)
FIGURE 35. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 36. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2027 (USD BILLION)
FIGURE 37. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 38. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2027 (USD BILLION)
FIGURE 39. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 40. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 41. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 42. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 43. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 44. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 45. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 46. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 47. AUSTRALIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 48. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 49. INDIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 50. INDONESIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 51. JAPAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 52. MALAYSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 53. PHILIPPINES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 54. SINGAPORE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 55. SOUTH KOREA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 56. TAIWAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 57. THAILAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 59. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 60. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 61. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 62. NETHERLANDS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 63. QATAR RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 64. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 65. SAUDI ARABIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 66. SOUTH AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 67. SPAIN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 68. UNITED ARAB EMIRATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 69. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 70. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET: FPNV POSITIONING MATRIX
FIGURE 71. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 72. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 4. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DSRNA, BY REGION, 2018-2027 (USD BILLION)
TABLE 5. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MIRNA, BY REGION, 2018-2027 (USD BILLION)
TABLE 6. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SIRNA, BY REGION, 2018-2027 (USD BILLION)
TABLE 7. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2027 (USD BILLION)
TABLE 8. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY AUTOIMMUNE HEPATITIS, BY REGION, 2018-2027 (USD BILLION)
TABLE 9. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY HEPATITIS B AND C, BY REGION, 2018-2027 (USD BILLION)
TABLE 10. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2027 (USD BILLION)
TABLE 11. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2027 (USD BILLION)
TABLE 12. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 13. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2027 (USD BILLION)
TABLE 14. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2027 (USD BILLION)
TABLE 15. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY AUTOIMMUNE HEPATITIS, BY REGION, 2018-2027 (USD BILLION)
TABLE 16. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY HEPATITIS B AND C, BY REGION, 2018-2027 (USD BILLION)
TABLE 17. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2027 (USD BILLION)
TABLE 18. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2027 (USD BILLION)
TABLE 19. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2027 (USD BILLION)
TABLE 20. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 21. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 22. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 23. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 24. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 25. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 26. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 27. AUSTRALIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 28. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 29. INDIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 30. INDONESIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 31. JAPAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 32. MALAYSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 33. PHILIPPINES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 34. SINGAPORE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 35. SOUTH KOREA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 36. TAIWAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 37. THAILAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 38. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 39. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 40. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 41. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 42. NETHERLANDS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 43. QATAR RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 44. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 45. SAUDI ARABIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 46. SOUTH AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 47. SPAIN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 48. UNITED ARAB EMIRATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 49. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 50. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET: SCORES
TABLE 51. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET: BUSINESS STRATEGY
TABLE 52. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET: PRODUCT SATISFACTION
TABLE 53. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET: RANKING
TABLE 54. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 55. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET: MERGER & ACQUISITION
TABLE 56. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 57. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 58. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET: INVESTMENT & FUNDING
TABLE 59. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 60. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET: LICENSE & PRICING

Companies Mentioned

Alnylam Pharmaceuticals Inc.
Ambion, Inc
Arcturus Therapeutics
Arrowhead Pharmaceuticals, Inc.
AstraZeneca plc
Atalanta Therapeutics
Bioneer Corporation
CureVac AG
Dicerna Pharmaceuticals
Gotham Therapeutics Corp.
Gradalis, Inc.
Invitrogen
Ionis Pharmaceuticals
Ionis Pharmaceuticals, Inc.
Merck KGaA
Phio Pharmaceuticals Inc.
Qiagen NV
Quark Pharmaceuticals, Inc.
Sanofi S.A.
Silence Therapeutics
Sirnaomics, Inc.
Thermo Fisher Scientific Inc.